Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

Best ideas from the 'best' investors


Bookmark and Share

 Ken Kam follows 70,000+ stock pickers who run virtual portfolios on Marketocracy; he looks for stocks bought by the 'best' while being sold by the 'rest'. Here's his two latest ideas.

"Sun Healthcare Group (NASDAQ : SUNH) is a small-cap, California-based, healthcare facility company that specializes in inpatient, rehabilitation, and medical staffing services.

Advertisement
Banner

"SUNH has 24,000 beds and 213 long-term care facilities in 25 states; 416 rehabilitation centers in 33 states and temporary medical staffing in 38 states.

"The 'best' investors have increased their holdings in the stock by 38%, while the 'rest' have decreased their positions by 1%. The Best Investors began purchasing SUNH in January 2005 at $8 and they would gradually increase those shares until selling some in July '06 at $8.

"Later, in January 2007, a significant purchase was made at $12, and many of those were then sold in May 20'08 at $14. Now, in the past two weeks, the Best Investors have purchased more shares of Sun Healthcare.

"L.B. Foster Co. (NASDAQ: FSTR) is a small-cap, Pittsburgh-based, Industrial Machinery company. FSTR specializes in manufacturing and distributing rail, construction and tubular products for rail, construction, energy and utility companies.

"They create rails, concrete ties, rail joints, precast concrete buildings, fabricated steel, bridge decking, coated pipes and threaded pipes.

"The 'best' increased their holdings by 12% while the 'rest' decreased their holdings by 1%. The Best Investors began purchasing FSTR in August 2003 at $5, and the stock has had an incredible ride ever since.

"In April 2005 they bought some at $9, and in May 2006 they bought some more at $25. Some sold FSTR in November 2006 at $22, but others kept onto it. Now, in the past two weeks, the Best Investors have purchased more shares of FSTR."


Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary